LAUSR

The activation of spinal astrocytes and release of neuroinflammatory mediators are important events in neuropathic pain (NP) pathogenesis. In this study, we investigated the role of Wnt10a/β‐catenin signalling in kindlin‐1‐mediated astrocyte activation using a chronic constriction injury (CCI) NP rat model. Using kindlin‐1 overexpression and knockdown plasmids, we assessed hyperalgesia, changes in spinal astrocyte activation and the release of inflammatory mediators in a NP rat model. We also performed coimmunoprecipitation, Western blotting and real‐time polymerase chain reaction (PCR) to characterize the underlying mechanisms of kindlin‐1 in astrocyte cultures in vitro. Kindlin‐1 was significantly upregulated in CCI rats and promoted hyperalgesia. Moreover, we observed increased kindlin‐1, Wnt10a and glial fibrillary acidic protein (GFAP; biomarker for astroglial injury) levels and the release of inflammatory mediators in NP rats (p < 0.05). Inhibiting GFAP in vitro led to decreased kindlin‐1 levels, prevented astrocyte activation, decreased Wnt10a level and the release of inflammatory mediators (p < 0.05). Coimmunoprecipitation showed that kindlin‐1 can interact with Wnt10a. We showed that kindlin‐1‐mediated astrocyte activation was associated with Wnt10a/β‐catenin signalling and the downstream release of inflammatory mediators in a CCI NP rat model. Our findings provide novel insights into the molecular mechanisms of kindlin‐1‐mediated astrocyte activation after CCI.